Thanks Russ for the info. I didn't know BOD threads were still listed. The deal doesn't change.The information supports my case. Your first reply to me was that at the time Allied was worth (m$) 14.8 and BOD (m$) 47.8. Therefore BOD brought 3 x the value to the table.
BOD had 188 million shares on issue yet paid Allied shareholders 428 million shares giving Allied shareholders 70% of The new merged company. Issued shares now at 611 million. If I recall a CR was done shortly after the merging of the 2 companies.
Allied claimed to have a profitable medical supply business and I noticed Lee Rodne was quoted as saying that he expected to increase the medical supply business to 20 to 30 million in 3 years.Stated in Biotech Daily May 2011.
That didn't happen. All he did was capital raise and dilute.
Global future, page-37
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.97 |
Change
-0.235(1.29%) |
Mkt cap ! $345.3M | |||
| Open | High | Low | Value | Volume |
| $18.09 | $18.09 | $17.88 | $1.182K | 66 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 60 | $17.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.05 | 554 | 1 |
View Market Depth
| Last trade - 14.30pm 10/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |